Versago Vascular Access Obtains $1,650,000 Seed Financing
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=1087f8a0-3f21-45ed-ad95-a3eb21dba04a - Date
2/25/2016 - Company Name
Versago Vascular Access - Mailing Address
375 West Street West Bridgewater, MA 02379 USA - Company Description
Versago is a true platform technology, spanning several fields with its unique design. Our patented technology displaces multiple traditional access applications in Apheresis and Chemotherapy, and opens several new ones such as Total Parenteral Nutrition, CAR-T and Hemodialysis. - Website
http://www.versagovascularaccess.com - Transaction Type
Venture Equity - Transaction Amount
$1,650,000 - Transaction Round
Seed - Proceeds Purposes
The company’s new funding will be used to further develop the Versago line of port technology, initiate regulatory review and conduct animal testing. - M&A Terms
- Venture Investor
Primo Medical Group - Venture Investor
Undisclosed
